Abiprubart
KPL-404-C221
Phase 2 small_molecule terminated
Quick answer
Abiprubart for Sjögrens Disease is a Phase 2 program (small_molecule) at Kiniksa Pharmaceuticals International, plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kiniksa Pharmaceuticals International, plc
- Indication
- Sjögrens Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated